NASDAQ: ODYSOdysightai Inc Stock
$3.44+0.08 (+2.38%)
Updated Dec 22, 2025
ODYS Price
$3.44
Fair Value Price
N/A
Market Cap
$56.26M
52 Week Low
$2.60
52 Week High
$7.02
P/E
-3.13x
P/B
1.93x
P/S
18.94x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.88M
Earnings
-$16.31M
Gross Margin
29.8%
Operating Margin
-420.41%
Profit Margin
-420.4%
Debt to Equity
0.13
Operating Cash Flow
-$13M
Beta
0.42
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ODYS Overview
Odysight.ai Inc., together with its subsidiaries, develops, produces, and markets visual sensing and AI-based video analytics solutions in Israel, the United States, the United Kingdom, and internationally. The company, through its visualization technology offers solutions across predictive maintenance and condition-based monitoring markets in various sectors, such as medical, defense, energy, automotive, transportation, aviation, maritime, and industrial non-destructing-testing. Odysight.ai Inc. is based in Omer, Israel.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ODYS's potential to beat the market
- ODYS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Scientific & Technical Instrument
Industry Rating
B
ODYS
RankedUnranked of 24
RankedUnranked of 24
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $161.99 | A | |
| $200.41 | B | |
| $38.73 | B |
Be the first to know about important ODYS news, forecast changes, insider trades & much more!
ODYS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ODYS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ODYS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ODYS is good value based on its book value relative to its share price (1.93x), compared to the US Scientific & Technical Instruments industry average (3.8x)
P/B vs Industry Valuation
ODYS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ODYS due diligence checks available for Premium users.
Valuation
ODYS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.13x
Industry
60.18x
Market
45x
ODYS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.93x
Industry
3.8x
ODYS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ODYS's financial health
Profit margin
Revenue
$149.0k
Net Income
-$4.4M
Profit Margin
-2,963.8%
ODYS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ODYS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$32.9M
Liabilities
$3.8M
Debt to equity
0.13
ODYS's short-term assets ($31.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ODYS's short-term assets ($31.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ODYS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ODYS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.4M
Investing
-$11.0k
Financing
$1.0k
ODYS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ODYS vs Scientific & Technical Instrument Stocks
Odysightai Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.